Viridian Therapeutics, Inc. (VRDN)
28.87
-1.52
(-5.00%)
USD |
NASDAQ |
Mar 05, 16:00
28.87
0.00 (0.00%)
After-Hours: 17:15
Viridian Therapeutics Free Cash Flow : -277.36M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -14.82M |
| ADMA Biologics, Inc. | 27.50M |
| Avantor, Inc. | 495.00M |
| Immunovant, Inc. | -423.09M |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.23M |
| Cash from Investing (Quarterly) | -339.42M |
| Cash from Financing (Quarterly) | 406.39M |
| Free Cash Flow Per Share (Quarterly) | -0.2593 |
| Free Cash Flow to Equity (Quarterly) | -51.34M |
| Free Cash Flow to Firm (Quarterly) | -21.19M |
| Free Cash Flow Yield | -11.33% |